Sales Force Login   Speaker Login   Distributor Locator   Contact Us    

  
 
Home > Clinical Products > Heel Protection > Delivers Advanced Protection
  Prevalon™ Heel Protector
  Prevalon™ Petite Heel Protector
  Prevalon™ Wedge
 
  Training Video
  MSDS Sheets
  Request Brochure
  Product Advertisement

Prevalon helps minimize pressure, friction and shear on the feet, heels and ankles of your non-ambulatory patients. This provides extra protection for at-risk heels, much more than special support services like beds, mattresses and overlays.11 Prevalon completely off-loads the heel delivering total, continuous pressure relief. It also helps minimize pressure, friction and shear on the feet and ankles. By maximizing support under the foot, it even helps prevent plantar flexion contracture (foot drop). The Prevalon™ Foot and Leg Stabilizer Wedge also helps prevent lateral foot and leg rotation.

Intervention with Prevalon for heel protection and silver alginate for wound dressing for two months completely closed wound from existing stage IV pressure ulcer and it eventually healed completely.15

 
Proven Results against Heel Pressure Ulcers
  • A study at a 550-bed nursing home aimed to assess the impact of a heel pressure ulcer protection protocol using Prevalon. The facility saw a 95% reduction in heel ulcer development and concluded that Prevalon "significantly reduces the risk of developing heel pressure ulcers in a high-risk population."11
  • facility saw a100% prevention in both heel ulcers and foot drop!13
  • A 5-month trial using Prevalon on all high-risk patients in one facility’s extended care unit showed a 93% decrease in heel pressure ulcers, and a subsequent 18-month trial of Prevalon in the acute care unit showed a 66% heel pressure ulcer reduction.14
  • Nurses also ranked Prevalon at a statistically significant, higher level of preference over a waffle-style competitor.2


Proven Financial Benefits
Besides a 100% prevention in both heel ulcers and foot drop, an evaluation of Prevalon in one facility compared to the projected costs of treating heel pressure ulcers revealed an annual revenue preservation of $1.9 million!13
 
References: 1. Amlung SR, Miller WL, Bosley LM, Adv Skin Wound Care. Nov/Dec 2001;14(6):297-301. 2. Walsh J, DeCampo M, Waggoner D, Keeping heels intact: evaluation of a protocol for prevention of facility-acquired heel pressure ulcers. Poster presented at the Symposium on advanced Wound Care, San Antonio, TX, Apr 2006. 3. Federal Register, Vol. 72 No.162, 2007 Aug: 47201-47205. 4. Beckrich K, Aronovitch SA, Nursing Economic. Sep/Oct 1999;17(5):263-71. 5. Maklebust J, Magnan MA, Adv Wound Care. Nov 1994;7(6):25, 27-8, 31-4 passim. 6. Levin M, Adv Wound Care. Mar/Apr 1997;10(2):24-30. 7. Wong VK, Stotts NA, JWOCN. Jul 2003; 30(4): 191-8. 8. Folkedahl BA, Frantz R, Prevention of pressure ulcers. Iowa City (IA) University of Iowa Gerontological Nursing Interventions Research Center, Research Dissemination Core; May 2002. 9. Young ZF, Evans A, Davis J, J Nurs Admin (JONA). Jul/Aug 2003;33(7/8):380-3. 10. Getting started kit: prevent pressure ulcers: how-to guide. Protecting 5 million lives from harm campaign, Institute for Healthcare Improvement (IHI), 2006. 11. Coats-Bennet U, Critical Care Nursing Quarterly. May 2002;25(1):22-32. 12. Burda V, A successful heel ulcer prevention program resulting in 95% reduction of heel ulcer incidence. Poster presented at the Symposium on Advanced Wound Care, Tampa, FL, Apr 2007. 13. Meyers T, et al., Successful prevention of heel pressure ulcers and foot drop in the high risk ventilation patient population. Poster presented at Institute for Healthcare Improvement (IHI), Orlando, FL, Dec 2007. 14. Brainard N, Ortiz L, Simple low cost intervention saves VA hospital thousands through reduction in heel injury. Poster presented at Institute for Healthcare Improvement (IHI), Orlando, FL, December 2007 15. Garrett D, Intervention with a new heel protection device and silver alginate dressing to prevent amputation of lower leg due to stage IV ulcer of the heel and malleolus. Case study conducted at Salem Village Nursing and Rehabilitation Center, Joliet IL, Oct 2006.
 
Clinical Products | Clinical Education | Company | Careers | Privacy Policy | Newsroom | Contact Us | Home | 800-323-2220
© Sage Products, Inc. 1997-2007 · 3909 Three Oaks Rd, Cary, IL 60013